Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

Clinical trial NCT07157787 · RECRUITING

Trial details

NCT number: NCT07157787
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Membranous Nephropathy

Start date: 2025-09-19
Primary completion: 2027-07-02
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.